Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer

INTRODUCTION: We conducted a presurgical trial to assess the tissue-related effects of metformin in overweight/obese breast cancer (BC) patients. METHODS: Metformin 1,500 mg daily was administered to 35 nondiabetics with stage 0–III BC, body mass index (BMI) ≥ 25 kg/m(2). The primary endpoint was tu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Invest
Main Authors: Kalinsky, Kevin, Crew, Katherine D., Refice, Susan, Xiao, Tong, Wang, Antai, Feldman, Sheldon M., Taback, Bret, Ahmad, Aqeel, Cremers, Serge, Hibshoosh, Hanina, Maurer, Matthew, Hershman, Dawn L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4435671/
https://ncbi.nlm.nih.gov/pubmed/24605899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07357907.2014.889706
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados